This is a summary of the study setup and most important findings of a scientific paper focusing on health economics of Woulgan published in Journal of Wound Care (JWC) July 2019. It is part of our “In a nutshell” series where we report the basics of all the scientific papers making up the Evidence for … Continue reading ›
This is a summary of the study setup and most important findings of a scientific paper published in Journal of Wound Care (JWC) in September 2018. It is part of our “In a nutshell” series where we report the basics of all the scientific papers making up the Evidence for Woulgan, to make the findings … Continue reading ›
Congratulations to poster prize winner, Mr Keith Cutting, Clinical Research Consultant from Hertfordshire, for his poster entitled: THE NATURE OF BETA-GLUCANS AND THE ROLE IN WOUND CARE OF A NOVEL BIOACTIVE BETA-GLUCAN GEL – WOULGAN.
The Woulgan team is proud to announce our participation at EWMA 2016 Conference in Bremen, Germany. The conference will take place from 11-13 May and has the theme PATIENTS. WOUNDS. RIGHTS.
When wound healing stalls, patients experience lower quality of life, clinician time increases exponentially, and healthcare systems spend precious resources to provide care that usually could have been prevented. This overview explores wound-healing, defines types of challenging wounds, and examines the effects of stalled wound healing on health systems and patients. Stages of wound healing … Continue reading ›
The allowed patent application has the application number US 13/989,594, title of invention: Glucan Gels. The claims cover the gel glucan product comprising SBG, a method of producing the gel glucan product and the product obtainable by this method as well as a medical composition comprising the gel glucan. “We are very pleased with this … Continue reading ›